COO
Price
$65.35
Change
-$2.04 (-3.03%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
13.4B
93 days until earnings call
DHR
Price
$203.84
Change
-$1.98 (-0.96%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
147.38B
56 days until earnings call
Interact to see
Advertisement

COO vs DHR

Header iconCOO vs DHR Comparison
Open Charts COO vs DHRBanner chart's image
Cooper Companies (The)
Price$65.35
Change-$2.04 (-3.03%)
Volume$87.44K
Capitalization13.4B
Danaher
Price$203.84
Change-$1.98 (-0.96%)
Volume$11.17K
Capitalization147.38B
COO vs DHR Comparison Chart in %
Loading...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COO vs. DHR commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a Hold and DHR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (COO: $67.39 vs. DHR: $205.82)
Brand notoriety: COO and DHR are both not notable
COO represents the Pharmaceuticals: Other, while DHR is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: COO: 159% vs. DHR: 50%
Market capitalization -- COO: $13.4B vs. DHR: $147.38B
COO [@Pharmaceuticals: Other] is valued at $13.4B. DHR’s [@Medical Specialties] market capitalization is $147.38B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.67B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.98B. The average market capitalization across the [@Medical Specialties] industry is $10.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COO’s FA Score shows that 0 FA rating(s) are green whileDHR’s FA Score has 0 green FA rating(s).

  • COO’s FA Score: 0 green, 5 red.
  • DHR’s FA Score: 0 green, 5 red.
According to our system of comparison, DHR is a better buy in the long-term than COO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COO’s TA Score shows that 4 TA indicator(s) are bullish while DHR’s TA Score has 5 bullish TA indicator(s).

  • COO’s TA Score: 4 bullish, 6 bearish.
  • DHR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, DHR is a better buy in the short-term than COO.

Price Growth

COO (@Pharmaceuticals: Other) experienced а -10.40% price change this week, while DHR (@Medical Specialties) price change was -2.82% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.31%. For the same industry, the average monthly price growth was +8.56%, and the average quarterly price growth was +30.22%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.10%. For the same industry, the average monthly price growth was +9.54%, and the average quarterly price growth was +9.36%.

Reported Earning Dates

COO is expected to report earnings on Dec 04, 2025.

DHR is expected to report earnings on Oct 28, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.31% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+0.10% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DHR($147B) has a higher market cap than COO($13.4B). DHR has higher P/E ratio than COO: DHR (43.70) vs COO (33.04). DHR YTD gains are higher at: -10.058 vs. COO (-26.689). DHR has higher annual earnings (EBITDA): 6.76B vs. COO (1.1B). DHR has more cash in the bank: 2.96B vs. COO (116M). COO has less debt than DHR: COO (2.59B) vs DHR (17.4B). DHR has higher revenues than COO: DHR (24B) vs COO (3.99B).
COODHRCOO / DHR
Capitalization13.4B147B9%
EBITDA1.1B6.76B16%
Gain YTD-26.689-10.058265%
P/E Ratio33.0443.7076%
Revenue3.99B24B17%
Total Cash116M2.96B4%
Total Debt2.59B17.4B15%
FUNDAMENTALS RATINGS
COO vs DHR: Fundamental Ratings
COO
DHR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
10080
SMR RATING
1..100
8579
PRICE GROWTH RATING
1..100
6458
P/E GROWTH RATING
1..100
9264
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DHR's Valuation (67) in the Medical Specialties industry is in the same range as COO (77). This means that DHR’s stock grew similarly to COO’s over the last 12 months.

DHR's Profit vs Risk Rating (80) in the Medical Specialties industry is in the same range as COO (100). This means that DHR’s stock grew similarly to COO’s over the last 12 months.

DHR's SMR Rating (79) in the Medical Specialties industry is in the same range as COO (85). This means that DHR’s stock grew similarly to COO’s over the last 12 months.

DHR's Price Growth Rating (58) in the Medical Specialties industry is in the same range as COO (64). This means that DHR’s stock grew similarly to COO’s over the last 12 months.

DHR's P/E Growth Rating (64) in the Medical Specialties industry is in the same range as COO (92). This means that DHR’s stock grew similarly to COO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COODHR
RSI
ODDS (%)
Bullish Trend 5 days ago
68%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
59%
Bullish Trend 5 days ago
58%
Momentum
ODDS (%)
Bearish Trend 5 days ago
63%
Bearish Trend 5 days ago
61%
MACD
ODDS (%)
Bearish Trend 5 days ago
57%
Bearish Trend 5 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
59%
Bearish Trend 5 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
59%
Bullish Trend 5 days ago
56%
Advances
ODDS (%)
Bullish Trend 7 days ago
60%
Bullish Trend 5 days ago
55%
Declines
ODDS (%)
Bearish Trend 13 days ago
59%
Bearish Trend 7 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
56%
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
67%
Bullish Trend 5 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BITI19.460.65
+3.46%
ProShares Shrt Bitcoin ETF
LIAT225.95N/A
N/A
LifeX 2059 Infl-Prt Longevity Inc ETF
MRCP30.65-0.10
-0.31%
PGIM S&P 500 Buffer 12 ETF - Mar
TSPA40.54-0.24
-0.59%
T. Rowe Price US Equity Research ETF
PBW25.28-0.39
-1.52%
Invesco WilderHill Clean Energy ETF

COO and

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been loosely correlated with A. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
+4.36%
A - COO
50%
Loosely correlated
+0.56%
ALC - COO
48%
Loosely correlated
+0.47%
DHR - COO
46%
Loosely correlated
+0.26%
SYK - COO
45%
Loosely correlated
+0.45%
BIO - COO
44%
Loosely correlated
+1.43%
More

DHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, DHR has been closely correlated with TMO. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if DHR jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DHR
1D Price
Change %
DHR100%
+0.26%
TMO - DHR
77%
Closely correlated
+0.61%
MTD - DHR
70%
Closely correlated
+1.40%
BIO - DHR
69%
Closely correlated
+1.43%
RVTY - DHR
69%
Closely correlated
+0.99%
WAT - DHR
68%
Closely correlated
+1.39%
More